Armistice Capital’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,250,000
| Closed | -$1.22M | – | 237 |
|
|
2025
Q1 | $1.22M | Buy |
1,250,000
+932,414
| +294% | +$908K | 0.02% | 154 |
|
|
2024
Q4 | $540K | Buy |
317,586
+27,586
| +10% | +$46.9K | 0.01% | 173 |
|
|
2024
Q3 | $824K | Buy |
290,000
+134,000
| +86% | +$381K | 0.01% | 172 |
|
|
2024
Q2 | $549K | Buy |
156,000
+7,505
| +5% | +$26.4K | 0.01% | 172 |
|
|
2024
Q1 | $878K | Sell |
148,495
-65,333
| -31% | -$386K | 0.01% | 165 |
|
|
2023
Q4 | $2.75M | Buy |
+213,828
| New | +$2.75M | 0.04% | 138 |
|
|
2019
Q2 | – | Sell |
-2,451
| Closed | -$179K | – | 69 |
|
|
2019
Q1 | $179K | Buy |
+2,451
| New | +$179K | 0.01% | 64 |
|